GAUSH MEDITECH (02407) wholly-owned subsidiary achieved a key milestone in MDR; and the self-developed hydrophilic acrylic intraocular lens (IOL) product portfolio obtained MDR CE certification.

GAUSH MEDITECH (02407) has announced that its wholly owned subsidiary, Teleon Surgical B.V., has reached an important milestone in transitioning from the Medical Devices Directive (MDD) to the Medical Devices Regulation (MDR). Their self-developed hydrophilic acrylic intraocular lens (IOL) product portfolio has received MDR CE certification from a designated verification body. This certification marks a significant step forward for the entire product portfolio based on the company's self-developed hydrophilic materials, all of which have obtained MDR CE certification. This achievement will lead to further cost reduction and long-term material security, demonstrating the dedication, expertise, and relentless efforts of the entire team. The hydrophilic acrylic LENTIS, FEMTIS, and VISIOTIS series of products, featuring advanced multifocal lens designs, offer significant benefits to both surgeons and patients. The innovative design optimizes light distribution, provides refractive stability, and improves contrast vision to enhance visual outcomes. Additionally, the hydrophilic acrylic materials ensure excellent biocompatibility, ensuring long-term patient satisfaction. With the milestone achieved and certification obtained, the company is able to bring innovative technology and products to more patients in the European and global markets.